According to a new report, published by KBV research, The Global Dermatome Device Market size is expected to reach $235.9 Million by 2030, rising at a market growth of 5.5% CAGR during the forecast period.
The Chronic Burn Care Treatments segment is leading the Global Dermatome Device Market by Application in 2022 thereby, achieving a market value of $82.5 Million by 2030. The increase in burn cases worldwide, particularly in developing nations like India, is responsible for the segment's expansion. Over 1,000,000 persons in India have mild to severe burns each year, according to the most recent statistics from the World Health Organization, which were published in 2018.
The Powered Dermatome Device segment has shown a growth rate of 5.3 % during (2023 - 2030). The powered dermatome devices collect donor split-thickness skin grafts (STSG) that can be applied as replacement skin for patients who have had skin excisions for burn wounds, skin cancer removal, and other skin loss areas. Achieving consistent graft thickness is crucial for successful skin grafting. Powered dermatomes ensure a more uniform graft thickness than manual techniques, where variability in pressure and technique may lead to uneven grafts. Consistent graft thickness enhances graft survival rates and improves the overall quality of wound healing.
The Hospitals segment is generating highest revenue share in the Global Dermatome Device Market by End-use in 2022 thereby, achieving a market value of $117.6 Million by 2030. This is due to the fact that patients who suffer from burns or trauma are typically transported to hospitals. A wide range of surgical operations can be performed in a hospital setting, including cosmetic surgery, general surgery, and the management of chronic burn situations. The segment is therefore anticipated to rise as product consumption increases in hospitals.
The North America market dominated the Global Dermatome Device Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $88.6 Million by 2030. The Europe market is experiencing a CAGR of 5.1% during (2023 - 2030). Additionally, The Asia Pacific market would showcase a CAGR of 6.3% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/dermatome-device-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, Aesculap, Inc. (B. Braun Melsungen AG), Surtex Instruments Ltd., Richard Wolf GmbH, Shaanxi Xingmao Industry Co., Ltd., Aygun Surgical Instruments Co., Inc. (CEECAT Capital), Humeca BV (Holland Venture), Nouvag AG and Novo Surgical Inc.
By Application
By Product
By End Use
By Geography
Companies Profiled
Unique Offerings 
